pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
AgnoMed
Phase 3 · small molecule · Primary Dysmenorrhea
AgnoMed for Primary Dysmenorrhea is a Phase 3 program (small_molecule) at Topiloric/Uriadec with 1 ClinicalTrials.gov record(s).
Internal code AgnoMed
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Topiloric/Uriadec
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Primary Dysmenorrhea
- Status
- active
- Trials
- 1